{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:07:49Z","timestamp":1786687669525,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Cryptococcosis is associated with high rates of morbidity and mortality. The limited number of antifungal agents, their toxicity, and the difficulty of these molecules in crossing the blood\u2013brain barrier have made the exploration of new therapeutic candidates against Cryptococcus neoformans a priority task. To optimize the antimicrobial functionality and improve the physicochemical properties of AMPs, chemical strategies include combinations of peptide fragments into one. This study aimed to evaluate the binding of the minimum activity motif of bovine lactoferricin (LfcinB) and buforin II (BFII) against C. neoformans var. grubii. The antifungal activity against these chimeras was evaluated against (i) the reference strain H99, (ii) three Colombian clinical strains, and (iii) eleven mutant strains, with the aim of evaluating the possible antifungal target. We found high activity against these strains, with a MIC between 6.25 and 12.5 \u00b5g\/mL. Studies were carried out to evaluate the effect of the combination of fluconazole treatments, finding a synergistic effect. Finally, when fibroblast cells were treated with 12.5 \u00b5g\/mL of the chimeras, a viability of more than 65% was found. The results obtained in this study identify these chimeras as potential antifungal molecules for future therapeutic applications against cryptococcosis.<\/jats:p>","DOI":"10.3390\/antibiotics11121819","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T03:43:49Z","timestamp":1671075829000},"page":"1819","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In Vitro Antifungal Activity of Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II against Cryptococcus neoformans var. grubii"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-9261","authenticated-orcid":false,"given":"Silvia Katherine","family":"Carvajal","sequence":"first","affiliation":[{"name":"Unidad de Prote\u00f3mica y Micosis Humanas, Grupo de Enfermedades Infecciosas, Departamento de Microbiolog\u00eda, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogot\u00e1 D.C. 110231, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4788-8150","authenticated-orcid":false,"given":"Yerly","family":"Vargas-Casanova","sequence":"additional","affiliation":[{"name":"Unidad de Prote\u00f3mica y Micosis Humanas, Grupo de Enfermedades Infecciosas, Departamento de Microbiolog\u00eda, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogot\u00e1 D.C. 110231, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9081-0546","authenticated-orcid":false,"given":"H\u00e9ctor Manuel","family":"Pineda-Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Chemistry Department, Universidad Nacional de Colombia, Carrera 45 No. 26\u201385, Building 451, Office 409, Bogot\u00e1 D.C. 111321, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6882-4397","authenticated-orcid":false,"given":"Javier Eduardo","family":"Garc\u00eda-Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Universidad Nacional de Colombia, Bogot\u00e1 Carrera 45 No. 26\u201385, Building 450, Bogot\u00e1 D.C. 111321, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6915-8488","authenticated-orcid":false,"given":"Zuly Jenny","family":"Rivera-Monroy","sequence":"additional","affiliation":[{"name":"Chemistry Department, Universidad Nacional de Colombia, Carrera 45 No. 26\u201385, Building 451, Office 409, Bogot\u00e1 D.C. 111321, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-5429","authenticated-orcid":false,"given":"Claudia Marcela","family":"Parra-Giraldo","sequence":"additional","affiliation":[{"name":"Unidad de Prote\u00f3mica y Micosis Humanas, Grupo de Enfermedades Infecciosas, Departamento de Microbiolog\u00eda, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogot\u00e1 D.C. 110231, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"He, Q., Ding, Y., Zhou, W., Li, H., Zhang, M., Shi, Y., and Su, X. (2017). Clinical features of pulmonary cryptococcosis among patients with different levels of peripheral blood CD4+ T lymphocyte counts. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2865-z"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lin, Y.Y., Shiau, S., and Fang, C.T. (2015). Risk factors for invasive Cryptococcus neoformans diseases: A case-control study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119090"},{"key":"ref_3","first-page":"w14281","article-title":"Common invasive fungal diseases: An overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med. Wkly."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"Aids"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: From environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Firacative, C., Trilles, L., and Meyer, W. (2022). Recent advances in cryptococcus and cryptococcosis. Microorganisms, 10.","DOI":"10.3390\/microorganisms10010013"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"675213","DOI":"10.1155\/2013\/675213","article-title":"Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An Atlas of the Molecular Types","volume":"2013","author":"Cogliati","year":"2013","journal-title":"Scientifica"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Escand\u00f3n, P., Lizarazo, J., Agudelo, C.I., and Casta\u00f1eda, E. (2018). Cryptococcosis in Colombia: Compilation and analysis of data from laboratory-based surveillance. J. Fungi., 4.","DOI":"10.3390\/jof4010032"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"697330","DOI":"10.3389\/fphar.2021.697330","article-title":"Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ashley, E.D. (2019). Antifungal drugs: Special problems treating central nervous system infections. J. Fungi., 5.","DOI":"10.3390\/jof5040097"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","article-title":"Cryptococcal meningitis: Improving access to essential antifungal medicines in resource-poor countries","volume":"13","author":"Loyse","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.43.8.1856","article-title":"Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans","volume":"43","author":"Mondon","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10989-021-10325-6","article-title":"Amanullah. A Review of Antimicrobial Peptides: Its Function, Mode of Action and Therapeutic Potential","volume":"28","author":"Nayab","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/00365549850161557","article-title":"Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin","volume":"30","author":"Vorland","year":"1998","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.150518097","article-title":"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: The proline hinge is responsible for the cell-penetrating ability of buforin II","volume":"97","author":"Park","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2000885","DOI":"10.1002\/cbdv.202000885","article-title":"Designing Chimeric Peptides: A Powerful Tool for Enhancing Antibacterial Activity","volume":"18","year":"2021","journal-title":"Chem. Biodivers."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Aguirre-Guataqui, K., M\u00e1rquez-Torres, M., Pineda-Casta\u00f1eda, H.M., Vargas-Casanova, Y., Ceballos-Garzon, A., Rivera-Monroy, Z.J., Garc\u00eda-Casta\u00f1eda, J.E., and Parra-Giraldo, C.M. (2022). Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II: Antifungal Activity against Reference Strains and Clinical Isolates of Candida spp.. Antibiotics, 11.","DOI":"10.3390\/antibiotics11111561"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0014-5793(03)00266-7","article-title":"Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure","volume":"540","author":"Yang","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s10989-021-10207-x","article-title":"Effects of Substituting Arginine by Lysine in Bovine Lactoferricin Derived Peptides: Pursuing Production Lower Costs, Lower Hemolysis, and Sustained Antimicrobial Activity","volume":"27","author":"Leal","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sun, C., Li, Y., Cao, S., Wang, H., Jiang, C., Pang, S., Hussain, M.A., and Hou, J. (2018). Antibacterial Activity and Mechanism of Action of Bovine Lactoferricin Derivatives with Symmetrical Amino Acid Sequences. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102951"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1442-200X.1994.tb03250.x","article-title":"A review: The active peptide of lactoferrin","volume":"36","author":"Tomita","year":"1994","journal-title":"Acta Paediatr. Jpn."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Arias, M., Piga, K.B., Hyndman, M.E., and Vogel, H.J. (2018). Improving the activity of trp-rich antimicrobial peptides by Arg\/Lys substitutions and changing the length of cationic residues. Biomolecules, 8.","DOI":"10.3390\/biom8020019"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1021\/jp405418y","article-title":"The different interactions of lysine and arginine side chains with lipid membranes","volume":"117","author":"Li","year":"2003","journal-title":"J. Phys. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1568026615666150703121009","article-title":"Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria","volume":"16","author":"Scocchi","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/bbrc.1998.8159","article-title":"Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions","volume":"244","author":"Park","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_28","first-page":"208","article-title":"Cell Penetrating Peptides as potential drug carriers","volume":"1","author":"Pulido","year":"2016","journal-title":"Bionatura"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Markowska, A., Markowski, A.R., and Jarocka-Karpowicz, I. (2021). The importance of 6-aminohexanoic acid as a hydrophobic, flexible structural element. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212122"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29580","DOI":"10.1039\/D0RA05937D","article-title":"Short peptides conjugated to non-peptidic motifs exhibit antibacterial activity","volume":"10","year":"2020","journal-title":"RSC Adv."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Gabald\u00f3n, T., Garcia-Rubio, R., Jenks, J.D., Hoenigl, M., Salzer, H.J.F., Ilkit, M., Lass-Fl\u00f6rl, C., and Perlin, D.S. (2020). Drug-resistant fungi: An emerging challenge threatening our limited antifungal armamentarium. Antibiotics, 9.","DOI":"10.3390\/antibiotics9120877"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/EC.00207-09","article-title":"Conservation of the sterol regulatory element-binding protein pathway and its pathobiological importance in Cryptococcus neoformans","volume":"8","author":"Chang","year":"2009","journal-title":"Eukaryot. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2958.2007.05676.x","article-title":"Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans","volume":"64","author":"Chang","year":"2007","journal-title":"Mol. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jord\u00e1, T., and Puig, S. (2020). Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae. Genes, 11.","DOI":"10.3390\/genes11070795"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.05502-11","article-title":"Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14\u03b1-demethylase (Erg11) residue critical for differential susceptibility between fluconazole\/voriconazole and itraconazole\/posaconazole","volume":"56","author":"Sionov","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kim, J.Y., Park, S.C., Noh, G., Kim, H., Yoo, S.H., Kim, I.R., Lee, J.R., and Jang, M.K. (2020). Antifungal effect of a chimeric peptide HN-MC against pathogenic fungal strains. Antibiotics, 9.","DOI":"10.3390\/antibiotics9080454"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/1535-7163.MCT-04-0077","article-title":"Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines","volume":"4","author":"Mader","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1074\/jbc.M208762200","article-title":"Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes","volume":"278","author":"Takeshima","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_39","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2008). Reference Method for Broth Dilution. Ref Method Broth Dilution Antifung Susceptibility Test Yeasts Approv Stand, Clinical and Laboratory Standards Institute (CLSI). [3rd ed.]. M27-A3."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.diagmicrobio.2015.01.010","article-title":"Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves","volume":"82","author":"Jauregizar","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_41","first-page":"1068","article-title":"Comparison of methods used for assessing the viability and vitality of yeast cells","volume":"14","year":"2014","journal-title":"FEMS Yeast Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00647","DOI":"10.1128\/mBio.00647-15","article-title":"Identification of a New Class of Antifungals Targeting the Synthesis of fungal sphingolipids","volume":"6","author":"Mor","year":"2015","journal-title":"mBio"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/12\/1819\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:41:44Z","timestamp":1760146904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/12\/1819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["antibiotics11121819"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11121819","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]}}}